Charles M. Baum - Jun 18, 2021 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Signature
/s/ Vickie Reed, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Jun 18, 2021
Transactions value $
-$6,278,633
Form type
4
Date filed
6/21/2021, 05:12 PM
Previous filing
Jun 9, 2021
Next filing
Dec 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Options Exercise $340K +40K +35.49% $8.49* 153K Jun 18, 2021 Direct F1
transaction MRTX Common Stock Sale -$790K -4.82K -3.15% $164.07 148K Jun 18, 2021 Direct F1, F2
transaction MRTX Common Stock Sale -$2.2M -13.3K -9.02% $164.90 135K Jun 18, 2021 Direct F1, F3
transaction MRTX Common Stock Sale -$3.46M -20.8K -15.47% $166.07 114K Jun 18, 2021 Direct F1, F4
transaction MRTX Common Stock Sale -$171K -1.02K -0.9% $166.73 113K Jun 18, 2021 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRTX Employee Stock Option (Right to Buy) Options Exercise $0 -40K -45.87% $0.00 47.2K Jun 18, 2021 Common Stock 40K $8.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 10, 2020.
F2 This transaction was executed in multiple trades at prices ranging from $163.45 to $164.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $164.47 to $165.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $165.53 to $166.52. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $166.53 to $166.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.